The Cardiovascular Research Foundation's (CRF) annual scientific symposium, the Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, will take place from October 23-26 at the Moscone Center in in San Francisco, California.
September 26, 2023 — The Cardiovascular Research Foundation's (CRF) annual scientific symposium, the Transcatheter Cardiovascular Therapeutics (TCT) conference, TCT 2023, will take place from October 23-26 at the Moscone Center in in San Francisco, California.
Now in its 35th year, TCT is described as the world’s premier meeting for interventional cardiovascular medicine. The four-day event is a global educational forum specializing in interventional cardiovascular medicine, offering a comprehensive, practical and interactive experience led by experts in coronary, structural, and endovascular interventions. TCT features cutting-edge research in interventional cardiovascular medicine that directly impacts patient care and how physicians treat heart disease.
This year, TCT planners report that its Program Directors will present an overview of 27 late-breaking clinical trials and scientific presentations. The event typically hosts 11,000+ attendees, 60% of which are U.S.-based and 40% outside the U.S., representing more than 100 countries. Over 5,000 physicians (30% U.S., 70% outside the U.S.) are expected to attend for deep-dive, topic-oriented practical, case-based sessions, with featured clinical research and other noteworthy sessions, hands-on training and extensive networking. In addition, more than 100 exhibitors will offer innovative products and solutions in the exhibit hall during the event.
For 2023, the TCT program directors, in collaboration with nearly 50 world-renowned thought leaders on the Program Development Committee, have designed a comprehensive program to foster engagement and interactive case-based learning with a diverse line-up of faculty. Program highlights and session plans follow.
Program Features
Opening introductory remarks on Tuesday, October 26 at 9:30 a.m. will begin day two of TCT 2023, followed by 6 clinical practice sessions, 6 moderated abstract presentations, 6 complex cases with the masters, and a total of 24 spotlight sessions. Two of those spotlight sessions will feature American Heart Association (AHA) Hot Takes sessions, part of AHA@TCT, which began last year.
The packed program offers multiple types of sessions, including: iCOACH Clinical Practice Sessions; Late-Breaking Clinical Trials and Science; Complex Cases with the Masters; Moderated Abstracts; Spotlight Sessions; and Special Events. Program planners have broken the wide range of sessions into a total of eight tracks, which include: Coronary; Live Cases; Mitral; Endovascular; Heart Failure; Tricuspid; TAVR; and LAA/PFO, for which many will have Spotlight Theater’s to accommodate participants.
Late-Breakers
The late-breaking clinical trials will be presented on Tuesday, Wednesday and Thursday from 11:00 a.m. – 12:30 p.m. and from 2:00 p.m. – 3:30 p.m. See Imaging Technology News' related content below for detailed sessions.
Live Cases
In the Structural Theater, on Tuesday, October 24 and Thursday October 26, from 3:30 p.m. – 5:00 p.m., participants will have an opportunity to learn from more than 40 live cases presented, remotely, which will be performed by leading experts from 18 of the world’s most distinguished medical institutions (listed on TCT2023 event website), which planners enthusiastically report offers the ability to watch complex procedures performed live by the masters.
Throughout the Moscone Center, CRF’s TCT program team is setting up easily-accessible areas for all of the educational and clinical programs. Six moderated abstract stations will present Emerging Clinical Science and Research throughout the event.
Special Programming and Events
The event will again hold its TCT MedTech Innovation Forum, schedule for Monday, October 23, from 8:00 a.m. – 5:45 p.m., with a networking reception to follow, from 5:45 p.m. – 6:45 p.m.
Also on Monday, the TCT Shark Tank Innovation Competition will take place from 12:15 p.m. – 1:45 p.m.
The Nurse and Technologist Symposium will be presented during TCT 2023 on Monday, from 9:00 a.m. – 5:30 p.m. Described as the premier full-day forum for front-line nurses, advanced practice providers, and technologists in or out of the cardiac cath lab, the Cardiovascular Research Foundation designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits.
TCT 2023 is CME-accredited for participants who attend in person. Planners note that CME credit can be earned in the following accredited learning locations: Coronary Spotlight; Structural Spotlight; Endovascular Spotlight; and the Nurse and Technologist Symposium.
The Cardiovascular Research Foundation (CRF) is a nonprofit organization specializing in interventional cardiology innovation, research, and education, and is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. The Foundation reports that for over 30 years, it has helped accelerate medical breakthroughs and educated doctors on the latest treatments for heart disease. CRF’s centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, and Structural Heart: The Journal of the Heart Team.
More information: www.tct2023.crfconnect.com; or www.crf.org
Related coverage:
CRF Announces TCT 2023 Late-breaking Clinical Trials
MedTech Innovation Forum Leads Day One at TCT 2023
Cardiovascular Research Foundation Announces Clinical Trials Center Executive Director
June 08, 2023 
